A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/138 (2006.01) A61P 25/22 (2006.01)
Patent
CA 2426069
Selective norepinephrine reuptake inhibitors are used to treat anxiety disorders, especially obsessive-compulsive disorder.
Selon la présente invention, des inhibiteurs spécifiques de recaptage de la noradrénaline sont utilisés dans le traitement de troubles anxieux, notamment du trouble obsessionnel-compulsif.
Michelson David
Read Holly Ann
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Treatment of anxiety disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of anxiety disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1698087